2023¶

Our Favorite Publications of 2023

2023 has been an incredible year for sequencing in diagnostic and public health labs. Thanks to the innovation and drive of molecular scientists, microbiologists, epidemiologists and laboratory technologists, major progress was made to bring sequencing closer to routine use.

As we look forward to all of the advances that 2024 is sure to bring, we took the opportunity to look back at our favorites from 2023. This list includes a mix of metagenomics, infection control and antimicrobial resistance; each of which is sure to have substantial impact on human health in the year to come and beyond.

Providing Reliable, Reproducible and Valid Results with Bioinformatic Versioning

BugSeq helps many clinical and public health labs to quickly identify pathogens, outbreaks, antimicrobial resistance and more. In order for labs to utilize BugSeq data, they need evidence that the results are both correct and reproducible. Imagine if a system diagnosed the same patient with different conditions depending on what day of the week it was - that system would not be very useful. More concretely, given a set of inputs, a system must produce the same outputs to be useful in a high-stakes setting. Our analysis solutions are no different - labs trust us not only for our accuracy, but also for our reproducibility. It allows them to rely on our results, and many customers have used this property to validate LDTs based on BugSeq. So how do we do it?